# Fatigue after cancer treatment: what actually works

Source: https://onco.cc/technologies/cancer-related-fatigue-management/  
OnCo record `cancer-related-fatigue-management` (Technology). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Fatigue is the commonest thing left behind by cancer treatment and the least treated: about a third of women in two large breast cancer cohorts still had severe fatigue years after diagnosis. What works is exercise, cognitive behavioural therapy and mindfulness programmes. What does not is the stimulant tablet people most often ask for, and the 2024 guideline says so.

## Summary

How long it lasts. In 763 long-term breast cancer survivors, about 34 per cent reported significant fatigue five to ten years after diagnosis, matching the prevalence at one to five years, and 21 per cent reported it at both points. In the French CANTO cohort, severe fatigue after treatment was present in 35.6 per cent at one year, 34.0 per cent at two and 31.5 per cent at four. A randomised trial of cognitive behavioural therapy opens with the figure that persistent fatigue is "a long-term adverse effect experienced by 30% to 40% of patients cured of cancer". It is not a short tail.

What works. The 2024 ASCO and Society for Integrative Oncology guideline update reviewed 113 randomised trials and recommends: "Clinicians should recommend exercise, CBT, mindfulness-based programs, and tai chi or qigong to reduce the severity of fatigue during cancer treatment. Psychoeducation and American ginseng may be recommended in adults undergoing cancer treatment. For survivors after completion of treatment, clinicians should recommend exercise, CBT, and mindfulness-based programs; in particular, CBT and mindfulness-based programs have shown efficacy for managing moderate to severe fatigue after treatment. Yoga, acupressure, and moxibustion may also be recommended." It also states that certainty and quality of evidence were low to moderate.

The comparison that settles the argument. A meta-analysis of 113 studies and 11,525 participants compared the three approaches directly: exercise had a weighted effect size of 0.30, psychological interventions 0.27, the two combined 0.26, and pharmaceutical interventions 0.09, which did not reach significance. The authors' recommendation is that "clinicians should prescribe exercise or psychological interventions as first-line treatments". A Cochrane review of 56 exercise studies in 4,068 participants found a standardised mean difference of -0.27, with aerobic exercise significantly reducing fatigue while resistance training and other forms did not reach significance. In the landmark cognitive behavioural therapy trial, 54 per cent of the treated group had a clinically significant improvement in fatigue severity against 4 per cent of those on the waiting list.

What does not work. The 2024 guideline is unusually direct: "Clinicians should not recommend L-carnitine, antidepressants, wakefulness agents, or routinely recommend psychostimulants to manage symptoms of CRF." Modafinil in 631 patients on chemotherapy helped only the subgroup with severe baseline fatigue and not those with mild or moderate fatigue, and a separate phase 3 trial during docetaxel found no difference on its primary endpoint with more nausea and vomiting. A meta-analysis of five psychostimulant trials in 426 participants found a small pooled effect, standardised mean difference -0.28, with "several trials failed to find any benefit over placebo". American ginseng in 364 patients missed its primary endpoint at four weeks and was significant at eight, with greater benefit in those still on treatment; the guideline says it may be recommended during treatment.

Before any of that, the treatable causes are worth excluding: anaemia, an underactive thyroid, low testosterone, depression, sleep apnoea, uncontrolled pain and the medicines that sedate. The 2014 guideline's instruction still stands, that everyone should be evaluated for fatigue after treatment and that moderate to severe fatigue warrants a comprehensive assessment.

What comes back, and when: partial, slowly, and not for everyone. Roughly a third are still severely fatigued years later, which is why fatigue is worth treating as a condition rather than waiting out. The treatments that work are behavioural and take weeks of effort, which is precisely why the tablet is asked for and why it is honest to say the tablet does not work.

## Fields

- Kind: Technology
- Status: standard-of-care
- Last checked: 2026-10-02
- Tags: rejuvenation; survivorship; evidence:strong
- Principle: Cancer-related fatigue is not relieved by rest, which separates it from ordinary tiredness. Proposed mechanisms include persistent inflammatory signalling, hypothalamic-pituitary-adrenal axis change, disrupted sleep architecture, deconditioning and the reinforcing cycle of reduced activity. Exercise and cognitive behavioural therapy both act on the deconditioning and the cycle, which is consistent with their being the two interventions that work.
- Strengths: A 2024 guideline naming exactly what to recommend and what not to; Direct meta-analytic comparison showing behavioural approaches beat drugs; Exercise and cognitive behavioural therapy are available without a prescription
- Limitations: The guideline rates certainty of evidence as low to moderate; Behavioural treatments need weeks of effort and are poorly funded; About a third remain severely fatigued years after treatment

## Sources

- Wikipedia: https://en.wikipedia.org/wiki/Cancer-related_fatigue
- Management of fatigue in adult survivors of cancer: ASCO and Society for Integrative Oncology guideline update (JCO 2024): https://doi.org/10.1200/JCO.24.00541
- Screening, Assessment, and Management of Fatigue in Adult Survivors of Cancer: ASCO guideline adaptation (JCO 2014): https://doi.org/10.1200/JCO.2013.53.4495
- Comparison of pharmaceutical, psychological and exercise treatments for cancer-related fatigue: meta-analysis (JAMA Oncol 2017): https://doi.org/10.1001/jamaoncol.2016.6914
- Exercise for the management of cancer-related fatigue in adults (Cochrane 2012): https://doi.org/10.1002/14651858.CD006145.pub3
- Cognitive behaviour therapy in severely fatigued disease-free cancer patients: randomised controlled trial (JCO 2006): https://doi.org/10.1200/JCO.2006.06.8270
- Phase 3 trial of modafinil for cancer-related fatigue in 631 patients receiving chemotherapy (Cancer 2010): https://doi.org/10.1002/cncr.25083
- Psychostimulants for the management of cancer-related fatigue: systematic review and meta-analysis (J Pain Symptom Manage 2011): https://doi.org/10.1016/j.jpainsymman.2010.06.020
- Wisconsin ginseng to improve cancer-related fatigue: randomised double-blind trial N07C2 (JNCI 2013): https://doi.org/10.1093/jnci/djt181
- Fatigue in long-term breast carcinoma survivors: a longitudinal investigation (Cancer 2006): https://doi.org/10.1002/cncr.21671
- Predictive model of severe fatigue after breast cancer diagnosis (CANTO) (JCO 2022): https://doi.org/10.1200/JCO.21.01252

## Connected records

- cancers: [Colorectal cancer](https://onco.cc/cancers/colorectal/), [Diffuse large B-cell lymphoma](https://onco.cc/cancers/dlbcl/), [HR-positive / HER2-negative breast cancer](https://onco.cc/cancers/breast-hr-positive/), [Non-small-cell lung cancer](https://onco.cc/cancers/nsclc/), [Prostate cancer](https://onco.cc/cancers/prostate/)
- fronts: [Diet, Exercise & Lifestyle](https://onco.cc/fronts/nutrition-lifestyle/), [Recovery & Rejuvenation](https://onco.cc/fronts/rejuvenation/), [Supportive Care & Survivorship](https://onco.cc/fronts/supportive-care/)
- technologies: [American ginseng for cancer-related fatigue](https://onco.cc/technologies/american-ginseng-fatigue/), [Cognitive behavioural therapy for fatigue and distress](https://onco.cc/technologies/cbt-fatigue-distress/), [Cognitive behavioural therapy for insomnia (CBT-I)](https://onco.cc/technologies/cbt-insomnia-cancer/), [Going back to work after cancer: the rates, and the programmes that change them](https://onco.cc/technologies/rejuv-life-return-to-work/), [Mindfulness-based stress reduction and cognitive therapy](https://onco.cc/technologies/mindfulness-based-interventions/), [Quality of life after transplant and cell therapy](https://onco.cc/technologies/rejuv-tx-quality-of-life/), [Sleep after cancer: how common insomnia is, how long it lasts, and the treatment that works](https://onco.cc/technologies/rejuv-mind-sleep-after-cancer/), [Structured exercise programmes after curative treatment](https://onco.cc/technologies/structured-exercise-survivorship/), [Survivorship care and late-effects surveillance](https://onco.cc/technologies/survivorship-care-plan/), [Tai chi and qigong](https://onco.cc/technologies/tai-chi-qigong/), [The exercise prescription after cancer: the dose the guidelines state](https://onco.cc/technologies/exercise-prescription-after-cancer/), [Thinking and memory after cancer treatment: what is measurable, and what helps](https://onco.cc/technologies/cognitive-impairment-after-cancer-treatment/)
- terms: [Cancer-related fatigue (tiredness)](https://onco.cc/terms/cancer-related-fatigue/), [Late effects and survivorship toxicity](https://onco.cc/terms/late-effects/), [Quality of life](https://onco.cc/terms/quality-of-life/)
- bottlenecks: [Survivorship and late effects are neglected](https://onco.cc/bottlenecks/b-survivorship/), [Toxicity and quality of life are undervalued](https://onco.cc/bottlenecks/b-toxicity-qol/)

---
JSON: https://onco.cc/api/v1/entities/cancer-related-fatigue-management.json